Dr. Amir Soheil Tolebeyan, MD

Dr. Tolebeyan practices at Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine.

Dr. Tolebeyan's NPI, 1053762682, was assigned on June 24, 2016. Dr. Tolebeyan holds Massachusetts license 290838.

Dr. Tolebeyan's primary practice is Tufts Medical Center, at 800 Washington Street, Boston, MA 02111 in Suffolk County. The practice phone is (617) 636-5000.

Dr. Tolebeyan's primary practice is Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine. Dr. Tolebeyan is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Lahey Clinic. Dmand AI also links Dr. Tolebeyan to 2 more hospitals, 4 medical groups, 1 group practice or clinic and 1 imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tolebeyan practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Tolebeyan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Tolebeyan's licenses on file in 5 states: Massachusetts, Connecticut, Missouri, New Hampshire and Wisconsin.

CMS data shows 22 Medicare services from Dr. Tolebeyan across 1 procedure code in 2024, all of them office visits, for 60 Medicare patients. Medicare paid $3,447 for them.

CMS counts 60 Medicare patients who saw Dr. Tolebeyan in 2024. The largest group is 65 to 74, with 20 patients. 70% of them have high cholesterol, and 68% have high blood pressure. 38% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tolebeyan's median patient age at 60, with 63% women.

In 2024, Dr. Tolebeyan wrote 748 Medicare Part D claims for 109 patients. 46% of them were for generic drugs. CMS names the drug for 631 of them, across 18 drugs with 11 or more claims each, at $462,151 in total drug cost. In 2023, CMS named 678 claims across 20 drugs.

Dr. Tolebeyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Tolebeyan, published from 2020 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Headache. Dr. Tolebeyan's most frequent co-authors are Deena Kuruvilla, MD and Vanessa Shakelia Cooper, MD.

CMS Open Payments shows 97 general payments to Dr. Tolebeyan from 27 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Abbvie Inc. paid the most, $7,203.